Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: EOSE stock price vs HON: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at HON's multiple
Needs HON P/S.
Implied fair value · at EOSE's multiple
Needs EOSE P/S.
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: EOSE FY 2025 (ended Dec 31, 2025) · HON FY 2025 (ended Dec 31, 2025).
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
Eos Energy Enterprises, Inc. · implied price per share
Bear
-$1.23
Base
-$1.44
Bull
-$1.66
Honeywell International Inc · implied price per share
Bear
$105.01
Base
$123.54
Bull
$142.07
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
-0.36x
2.51x
Net debt / EBITDA
Leverage against operating earnings
-0.26x
2.70x
Cash and equivalents
Liquid reserves on the balance sheet
$567.99M
$12.93B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
$813.64M
$34.94B
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
Based on an earlier data snapshot. Review the filing dates below or refresh after signing in.
If you believe EOSE can rapidly convert its 631.8% revenue growth into durable positive gross and operating margins, then hold or buy selectively; otherwise, the -82.8% HON-implied downside and -3.26 Altman Z-Score argue for avoiding the stock on a relative valuation basis because the current price is not supported by profitability or quality.
EOSE trades at a very large premium to HON on revenue-based valuation despite much weaker profitability and balance-sheet quality. HON-implied price of $1.22 is far below the current $7.08, implying -82.8% downside, while the stock still sits near the upper end of its historical band.
Supporting Metrics
Price unavailable
